Commercial Cell-based Therapies for Musculoskeletal Injuries in Horses

Research output: Contribution to journalReview articlepeer-review


Several cell-based therapeutic options to treat musculoskeletal injuries in horses are commercially available. The current literature supports the use of cell-based therapies to treat equine musculoskeletal injuries. Researchers continue to search for more effective cell-based therapies to provide practitioners with optimal treatment tools for musculoskeletal injuries in horses. Cell-based therapies require specialized facilities and technical competencies that might not be available or economically justifiable in many private practices. This review provides a summary of current commercially available cell-based therapeutic products for equine applications, their similarities and differences, and current objective data relating to their clinical efficacy.

Original languageEnglish (US)
Pages (from-to)363-371
Number of pages9
JournalVeterinary Clinics of North America - Equine Practice
Issue number2
StatePublished - Aug 2011


  • Adipose tissue-derived stromal vascular fraction cells
  • Bone marrow aspirate concentrate
  • Bone marrow-derived mesenchymal stem cells
  • Embryonic-like stem cells

ASJC Scopus subject areas

  • Equine


Dive into the research topics of 'Commercial Cell-based Therapies for Musculoskeletal Injuries in Horses'. Together they form a unique fingerprint.

Cite this